Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Cigna is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-10-09Current report (material event)
- 8-K2026-09-30Current report (material event)
- 10-Q2026-07-30Quarterly report
- 8-K2026-07-30Current report (material event)
- 11-K2026-06-2411-K
- 8-K2026-05-13Current report (material event)
- 10-Q2026-04-30Quarterly report
- 8-K2026-04-30Current report (material event)
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- 8-K2026-04-27Current report (material event)
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- ARS2026-03-13Annual report to holders
- DEFA14A2026-03-13DEFA14A
- DEF 14A2026-03-13Proxy statement
- SCHEDULE 13G/A2026-03-05SCHEDULE 13G/A
- 8-K2026-03-03Current report (material event)
- 8-K2026-02-27Current report (material event)
- 10-K2026-02-26Annual report
- 8-K2026-02-05Current report (material event)
- 8-K2025-11-18Current report (material event)
- SCHEDULE 13G/A2025-11-05SCHEDULE 13G/A
- 10-Q2025-10-30Quarterly report
- 8-K2025-10-30Current report (material event)
- 8-K2025-10-20Current report (material event)
- 8-K2025-09-04Current report (material event)
- 424B52025-09-04Prospectus (offering)
- FWP2025-09-03FWP
- 424B52025-09-02Prospectus (offering)
- S-3ASR2025-09-02S-3ASR
- 8-K2025-09-02Current report (material event)
- 10-Q2025-07-31Quarterly report
- 8-K2025-07-31Current report (material event)
- 8-K/A2025-07-28Current report (amended)
- 11-K2025-06-2711-K
- 8-K2025-06-02Current report (material event)
- 8-K2025-05-20Current report (material event)
- 10-Q2025-05-02Quarterly report
- 8-K2025-05-02Current report (material event)
- SCHEDULE 13G/A2025-04-30SCHEDULE 13G/A
- 8-K2025-04-28Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.